{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:10:06Z","timestamp":1793214606062,"version":"4.5.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijo.ijo_966_20","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T13:06:33Z","timestamp":1597928793000},"page":"1929","source":"Crossref","is-referenced-by-count":19,"title":["Biological therapy in refractory cases of uveitis and scleritis: An analysis of 18 cases from a tertiary eye care center from South India"],"prefix":"10.4103","volume":"68","author":[{"given":"Jyotirmay","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumen","family":"Sadhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthopratim","family":"Dutta Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.292599-1","first-page":"509456","article-title":"Uveitis in the aging eye: Incidence, patterns, and differential diagnosis?","author":"Abdulaal","year":"2015","journal-title":"J Ophthalmol"},{"key":"key-10.4103\/0301-4738.292599-2","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","author":"Jaffe","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.292599-3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10067-016-3480-x","article-title":"Efficacy and safety of adalimumab in Beh\u00e7et's disease-related uveitis: A multicenter retrospective observational study","author":"Fabiani","year":"2017","journal-title":"Clin Rheumatol"},{"key":"key-10.4103\/0301-4738.292599-4","first-page":"509","article-title":"Standardization of uveitis nomenclature for reporting clinical data.Results of the First International Workshop","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.292599-5","doi-asserted-by":"crossref","unstructured":"Krupa LZ, Kennedy HJ, Jamieson CP, Fisher N, Hart AR. The reasons for discontinuation of infliximab treatment in patients with Crohn's disease: A review of practice at NHS Teaching Hospital. ISRN Gastroenterol 2011;2011;672017. doi: 10.5402\/2011\/672017.","DOI":"10.5402\/2011\/672017"},{"key":"key-10.4103\/0301-4738.292599-6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/1744666X.2017.1288097","article-title":"Adalimumab for the treatment of uveitis","author":"LaMattina","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"key-10.4103\/0301-4738.292599-7","first-page":"560632","article-title":"Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis?","author":"Garc\u00eda-De-Vicu\u00f1a","year":"2013","journal-title":"Mediators Inflamm"},{"key":"key-10.4103\/0301-4738.292599-8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/art.10815","article-title":"Mapping the HLA association in Beh\u00e7et's disease: A role for tumor necrosis factor polymorphisms?","author":"Ahmad","year":"2003","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0301-4738.292599-9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12886-018-0929-5","article-title":"Conventional immunosuppressive therapy in severe Behcet's Uveitis: The switch rate to the biological agents","author":"Celiker","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"key-10.4103\/0301-4738.292599-10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2015.06.005","article-title":"Efficacy of anti-TNF alpha in severe and\/or refractory Beh\u00e7et's disease: Multicenter study of 124 patients","author":"Vallet","year":"2015","journal-title":"J Autoimmun"},{"key":"key-10.4103\/0301-4738.292599-11","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.ophtha.2014.04.044","article-title":"Rituximab therapy for refractory scleritis: Results of a phase I\/II dose-ranging, randomized, clinical trial","author":"Suhler","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.292599-12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.rbr.2017.05.003","article-title":"Incidence of tuberculosis among patients with rheumatoid arthritis using TNF blockers in Brazil: Data from the Brazilian Registry of Biological Therapies in Rheumatic Diseases (Registro Brasileiro de Monitora\u00e7\u00e3o de Terapias Biol\u00f3gicas-BiobadaBrasil)","author":"Yonekura","year":"2017","journal-title":"Rev Bras Reumatol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:52:48Z","timestamp":1786733568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_966_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"alternative-id":["292599"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_966_20","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}